Lineage Cell Therapeutics Inc logo

Lineage Cell Therapeutics Inc

STU:BT3 (USA)  
€ 0.76 (-6.75%) Jun 19
At Loss
P/B:
2.32
Market Cap:
€ 156.48M ($ 167.52M)
Enterprise V:
€ 118.89M ($ 127.28M)
Volume:
-
Avg Vol (2M):
-
Trade In:

Lineage Cell Therapeutics Inc Valuation Measures